Drug Shortage Report for PENTAMIDINE ISETIONATE FOR INJECTION BP

Last updated on 2018-04-20 History
Report ID 43643
Drug Identification Number 02183080
Brand name PENTAMIDINE ISETIONATE FOR INJECTION BP
Common or Proper name PENTAMIDINE ISETIONATE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) PENTAMIDINE ISETIONATE
Strength(s) 300MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 5 x 300mg GVL
ATC code P01CX
ATC description AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-26
Actual start date
Estimated end date
Actual end date 2018-04-19
Shortage status Resolved
Updated date 2018-04-20
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-04-20 English Compare
v7 2018-04-19 French Compare
v6 2018-04-19 English Compare
v5 2018-04-04 French Compare
v4 2018-04-04 English Compare
v3 2018-03-27 English Compare
v2 2018-03-21 French Compare
v1 2018-03-21 English Compare